Board Meetings for ASTRAZEN
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| ASTRAZEN | AstraZeneca Pharma India Limited | 27 Jul 2009 | Unaudited Financial Results | Inter alia, to consider and approve the un-audited financial results of the Company for the quarter and half-year ended June 30, 2009. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 23 Apr 2009 | Unaudited Financial Results for the qtr ended March 31, 2009 | - | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 18 Feb 2009 | Audited Financial Results and Dividend | Inter alia to consider and approve the Audited Financial Results of the Company for the last quarter and financial year ended December 31, 2008 and to recommend dividend, if any. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 23 Oct 2008 | Unaudited financial results for qtr ended September 30, 2008 | - | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 29 Jul 2008 | Unaudited Financial Results | Inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter and half year ended June 30, 2008. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 28 Apr 2008 | Unaudited Financial Results for the qtr ended March 31, 2008 | - | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 25 Feb 2008 | Audited Accounts and Dividend | Inter-alia to consider and approve the audited annual accounts for the year ended December 31, 2007 and to recommend Dividend, if any. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 26 Oct 2007 | Unaudited Financial Results for the Qtr ended Sept 30, 2007 | - | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 26 Jul 2007 | Unaudited Financial Results | Inter alia to consider and approve the Unaudited Financial Results for the quarter and half year ended June 30, 2007. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 30 Apr 2007 | Unaudited Financial Results | Inter-alia to consider and approve the Unaudited Financial Results for the first quarter ended 31st March, 2007. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 17 Mar 2007 | Interim Dividend/Record date/Others | To inter-alia consider the following business: 1) To consider revocation of recommended Dividend for the year ended December 31, 2006. 2) To consider payment of Interim Dividend for the year ended December 31, 2006, for which a Record Date of March 24, 2007 has been fixed. 3) To revise the Book Closure Dates fixed for the ensuing Annual General Meeting (AGM) scheduled on April 30, 2007 from April 23, 2007 - April 30, 2007 to April 27, 2007 to April 30, 2007 (both days inclusive). 4) To consider the approval of the revised Audited Accounts for the financial year ended December 31, 2006, after incorporating necessary changes as to the revocation of recommended dividend and payment of Interim Dividend for period ended December 31, 2006 and to make consequential changes in the Notice for the AGM and the Directors' Report. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 23 Feb 2007 | Audited Accounts and Dividend | Inter-alia to consider and approve the audited annual accounts for the year ended 31st December, 2006 and to recommend Dividend, if any. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 28 Oct 2006 | Unaudited Financial Results | Inter alia to consider and approve unaudited financial results for the quarter and nine months ended September 30,2006. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 08 Sept 2006 | Miscellaneous | To consider inter alia, a proposal for issue by the Company of secured fully paid bonus debentures from its General Reserve in terms of a Scheme of Arrangement between the Company and its Shareholders pursuant to Section 391 read with Section 393 of the Companies Act, 1956, the consideration of which was deferred at the last Board meting held on August 28, 2006. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 28 Aug 2006 | Scheme of Arrangement | Inter alia, a proposal for issue by the Company of secured fully paid bonus debentures from its General Reserve in terms of a Scheme of Arrangement between the Company and its Shareholders pursuant to section 391 read with section 393 of the Companies Act, 1956, a draft of which Scheme will be tabled at the meeting for consideration. | - |